Gene therapy for retinal and choroidal diseases

Expert Opinion on Biological Therapy

Volumn 2, Issue 5, 2002, Pages 537-544

  Campochiaro, Peter A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Gene therapy; Neovascularisation; Neurotrophic factors; Proliferative retinopathies; Retinal degenerations

Indexed keywords

ADENOVIRUS VECTOR; ANGIOSTATIN; CILIARY NEUROTROPHIC FACTOR; ENDOSTATIN; GENE PRODUCT; PIGMENT EPITHELIUM DERIVED FACTOR; PROTEIN BCL 2; PROTEIN RPE65; RIBOZYME; TISSUE INHIBITOR OF METALLOPROTEINASE 3; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; CHOROID DISEASE; DOG; GENE EXPRESSION; GENE MUTATION; GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; LEBER CONGENITAL AMAUROSIS; MOUSE; NONHUMAN; PHOTORECEPTOR; PIGMENT EPITHELIUM; RAT; RETINA DEGENERATION; RETINA DISEASE; RETINA NEOVASCULARIZATION; REVIEW; SUBRETINAL NEOVASCULARIZATION; VIRAL GENE DELIVERY SYSTEM; VISION; ANIMAL; GENE DELETION; GENE VECTOR; HUMAN; PHYSIOLOGY; SURVIVAL;

ANIMAL; CHOROIDAL NEOVASCULARIZATION; GENE DELETION; GENE THERAPY; GENETIC VECTORS; HUMAN; PHOTORECEPTORS, VERTEBRATE; PIGMENT EPITHELIUM OF EYE; RETINAL DISEASES; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; SURVIVAL; ANIMALS; HUMANS;

ADENOVIRIDAE; ANIMALIA; CANIS FAMILIARIS;

EID: 0035987409     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712598.2.5.537     Document Type: Review

References (97)

1. Inherited retinal dystrophy in the RCS rat: Prevention of photoreceptor degeneration by pigment epithelial cell transplantation
2. In vivo gene transfer into murine corneal endothelial and trabecular meshwork cells
3. Intraocular adenoviral vector-mediated gene transfer is increased in proliferative retinopathies
4. Recombinant adenovirus-mediated gene delivery into the rat retinal pigment epithelium in vivo
5. Recombinant adenovirus-mediated gene transfer into the adult rat retina
6. Adenovirus-mediated gene transfer to retinal ganglion cells
7. Humoral response after administration of E1-deleted adenoviruses: Immune privilege of the subretinal space
8. Immune responses limit adenovirally mediated gene expression in the adult mouse eye
9. Combined effect of cyclosporine and sirolimus on improving the longevity of recombinant adenovirus-mediated transgene expression in the retina
10. Encapsidated adenovirus mini-chromosome-mediated delivery of genes to the retina: Application to the rescue of photoreceptor degeneration
11. Efficient photoreceptor-targeted gene expression in vivo by recombinant adeno-associated virus
12. Real-time, noninvasive in vivo assessment of adrno-associated virus-mediated retinal transduction
13. Adeno-associated virus gene transfer to mouse retina
14. Stable transgene expression in rod photoreceptors after recombinant adeno-associated virus-mediated gene transfer to monkey retina
15. Reporter expression persists 1 year after adeno-associated virus-mediated gene transfer to the optic nerve
16. AAV-mediated gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization
17. Gene transfer into human lymphocytes by a defective human immunodeficiency virus Type 1 vector
18. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector
19. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector
20. Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector
21. Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors
22. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo
23. Self-activating lentivirus vectors for safe and efficient in vivo gene delivery
24. Lentivirus-mediated transduction of islet grafts with interleukin 4 results in sustained gene expression and protection from insulitis
25. Development of a novel trans-lentiviral vector that affords predictable safety
26. Development of lentiviral vectors for gene therapy for human disease
27. Lentiviral vectors: Excellent tools for experimental gene transfer and promising candidates for gene therapy
28. Lentiviral vectors: Turning a deadly foe into a therapeutic agent
29. Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector
30. Sustained transduction of ocular cells with a bovine immunodeficiency viral vector
31. Cytotoxicity of replication-defective mutant of Herpes simplex virus Type 1
32. Helper virus-free transfer of Herpes simplex virus Type 1 plasmid vectors into neural cells
33. Gene transfer to neurons using herpes simplex virus-based vectors
34. Inflammatory effects of gene transfer into the CNS with defective HSV-1 vectors
35. Herpes simplex virus-mediated gene delivery to the rodent visual system
36. Inhibition of experimental proliferative vitreoretinopathy by retroviral vector-mediated transfer of suicide gene
37. Retinitis pigmentosa and allied diseases. Implications of genetic heterogeneity
38. Molecular genetics of human retinal disease
39. Recessive mutations in the gene encoding the beta subunit of rod phosphodiesterase in patients with retinitis pigmentosa
40. Identification of a nonsense mutation in the rod photoreceptor cGMP phosphodiesterase beta-subunit gene of the rd mouse
41. Irish setter dogs affected with cone/rod dysplasia contain a nonsense mutation in the rod cGMP phosphodiesterase beta-subunit gene
42. Photoreceptor cell rescue in retinal degeneration (rd) mice by in vivo gene therapy
43. Rescue from photoreceptor degeneration in the rd mouse by human immunodeficiency virus vector-mediated gene transfer
44. Rescue of photoreceptor function by AAV-mediated gene transfer in a mouse model of inherited retinal degeneration
45. Molecular cloning, primary structure, and orientation of the vertebrate photoreceptor cell protein peripherin in the rod outer segment disk membrane
46. Identification of a photoreceptor-specific mRNA encoded by the gene responsible for retinal degeneration slow (rds)
47. Photoreceptor peripherin is the normal product of the gene responsible for retinal degeneration in the rds mouse
48. Restoration of photoreceptor ultrastructure and function in retinal degeneration slow mice by gene therapy
49. Gene replacement therapy in the retinal degeneration slow (rds) mouse: The effect on retinal degeneration following partial transduction of the retina
50. Mutations in MERTK, the human orthologue of the RCS rat retinal dystrophy gene, cause retinitis pigmentosa
51. Mutation of the receptor tyrosine kinase gene Mertk in the retinal dystrophic RCS rat
52. Correction of the retinal dystrophy phenotype of the RCS rat by viral gene transfer of Mertk
53. RPE65 is necessary for production of 11-cis-vitamin A in the retinal visual cycle
54. Mutations in RPE65 cause Leber's congenital amaurosis
55. Mutations in RPE65 cause autosomal recessive childhood-onset severe retinal dystrophy
56. Congenital stationary night blindness in the dog: Common mutation in the RPE65 gene indicates founder effect
57. Gene therapy restores vision in a canine model of childhood blindness
58. Gyrate atrophy of the choroid and retina with hyperornithinemia HOGA
59. Gyrate atrophy of the retina: Inborn error of L-ornithine: 2-oxoacid aminotransferase
60. Phenotype correction in retinal pigment epithelium in murine mucopolysaccharidosis VII by adenovirus-mediated gene transfer
61. Ribozyme-targeted destruction of RNA associated with autosomal-dominant retinitis pigmentosa
62. Ribozyme rescue of photoreceptor cells in a transgenic rat model of autosomal dominant retinitis pigmentosa
63. Ribozyme rescue of photoreceptor cells in P23H transgenic rats: Long-term survival and late-stage therapy
64. Adenovirus-mediated gene transfer of ciliary neurotrophic factor can prevent photoreceptor degeneration in the retinal degeneration (rd) mouse
65. Intraocular gene transfer of ciliary neurotrophic factor prevents death and increases responsiveness of rod photoreceptors in the retinal degeneration slow mouse
66. Long-term protection of retinal structure but not function using rAAV.CNTF in animal models of retinitis pigmentosa
67. Retinal degeneration is slowed in transgenic rats by AAV-mediated delivery of FGF-2
68. Fibroblast growth factor-2 decreases hyperoxia-induced photoreceptor cell death in mice
69. Adenovirally expressed basic fibroblast growth factor rescues photoreceptor cells in RCS rats
70. Ocular cell transfection with the human basic fibroblast growth factor gene delays photoreceptor cell degeneration in RCS rats
71. Glial cell line derived neurotrophic factor delays photoreceptor degeneration in a transgenic rat model of retinitis pigmentosa
72. Bcl-2/Bax: A rheostat that regulates an antioxidant pathway and cell death
73. Adenovirus-mediated delivery of rhodopsin-promoted bcl-2 results in a delay in photoreceptor cell death in the rd/rd mouse
74. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years
75. Argon laser photocoagulation for neovascular maculopathy: Five year results from randomized clinical trials
76. Retinal and choroidal neovascularization
77. Dramatic inhibition of retinal and choroidal neovascularization by oral administration of a kinase inhibitor
78. Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization
79. VEGF is major stimulator in model of choroidal neovascularization
80. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma
81. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
82. Antiangiogenic activity of the cleaved conformation of the serpin antithrombin
83. Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides
84. A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin
85. Pigment epithelium-derived factor: A potent inhibitor of angiogenesis
86. Inhibition of choroidal neovascularization by intravenous injection of adenoviral vectors expressing secretable endostatin
87. PEDF: A pigment epithelium derived factor with potent neuronal differentiating activity
88. Pigment epithelium-derived factor: Neurotrophic activity and identification as a member of the serine protease inhibitor gene family
89. Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization
90. Regression of ocular neovascularization by increased expression of pigment epithelium-derived factor
91. Suppression of choroidal neovascularization by adeno-associated virus vector expressing angiostatin
92. Inhibition of experimental choroidal neovascularization by overexpression of tissue inhibitor of metalloproteinases-3 in retinal pigment epithelial cells
93. Systemically expressed soluble Tie2 inhibits intraocular neovascularization
94. Experimental subretinal neovascularization is inhibited by adenovirus-mediated soluble VEGF/flt-1 receptor gene transfection: A role of VEGF and possible treatment for SRN in age-related macular degeneration
95. Inhibition of angiogenesis by adenovirus-mediated sFlt-1 expression in a rat model of corneal neovascularization
96. Periocular injection of an adenoviral vector expressing the extracellular portion of vascular endothelial growth factor receptor-1 (Adsflt.10) inhibits choroidal neovascularization (CNV)
97. Periocular adenovirus-mediated delivery of pigment epithelium-derived factor inhibits choroidal neovascularization